During the past 15 years, our research group has transplanted fetal/neonatal
cardiomyocytes, mesenchymal stem cells, and embryonic stem cell-derived cardiomyocytes …

Myocardial cell-replacement strategies are hampered by limited sources for human
cardiomyocytes and by significant cell loss following transplantation. We tested the …

Cellular transplantation has emerged as a potential approach to treat diseased hearts.
Although cell transplantation can affect global heart function, it is not known if this results …

Bone-marrow-derived cells and heart repair : Current Opinion in Organ Transplantation
Bone-marrow-derived cells and heart repair : Current Opinion in Organ Transplantation Log in …

Background Cardiac cell transplantation is compromised by low cell retention and poor graft
viability. Here, the effects of co-injecting adipose tissue-derived stem cells (ASCs) with …

Background—Mesenchymal stem cells (MSCs) have the potential to replace infarct scar, but
the long-term effects are unknown. We studied short-and long-term effects of MSC …

Stem cell transplantation has emerged as a novel treatment option for ischemic heart
disease. Different cell types have been utilized and the recent development of induced …

Objective We sought to understand the cellular and tissue-level changes underlying the
attenuation of adverse remodeling by cardiosphere transplantation in acute myocardial …

The deficit in left ventricular performance in an ischemically damaged heart is characterized
by depletion of functioning cardiomyocytes. The problem is accentuated by the inadequate …

Objective: Whether bone marrow cells injected following acute myocardial infarction (MI)
transdifferentiate into cardiomyocytes remains controversial, and how these cells affect …